WINTON GROUP Ltd

Position in EDIT — Editas Medicine, Inc.

CIK 1612063 LONDON, X0

Position in EDIT

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$141,588

+$33,402 QoQ

Shares Held

43,700

-0.2% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#86

of 216 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. EDIT ranks #66 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	254,408	$28,839,690
2	FTRE	Fortrea Holdings Inc.	389,155	$6,771,297
3	EXEL	Exelixis, Inc.	99,834	$5,431,967
4	TECH	BIO-TECHNE Corp	67,227	$4,749,587
5	HALO	Halozyme Therapeutics, Inc.	60,348	$4,723,437
6	VKTX	Viking Therapeutics, Inc.	90,546	$3,532,199
7	ALNY	Alnylam Pharmaceuticals, Inc.	7,880	$2,372,116
8	TRVI	Trevi Therapeutics, Inc.	106,852	$1,992,789

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$141,588	43,700	-0.2%	Shares	Sole	2026-08-07
2026-03-31	$108,186	43,800	+110.3%	Shares	Sole	2026-05-12
2023-03-31	$150,974	20,824	-1.4%	Shares	Sole	2023-05-12
2022-12-31	$187,423	21,130	+6.0%	Shares	Sole	2023-02-14
2022-09-30	$243,930	19,929	-11.0%	Shares	Sole	2022-11-10
2022-06-30	$265,015	22,402	+27.0%	Shares	Sole	2022-08-10
2022-03-31	$335,436	17,636	+23.1%	Shares	Sole	2022-05-11
2021-12-31	$380,434	14,329	+85.5%	Shares	Sole	2022-02-10
2020-12-31	$541,459	7,723	-83.0%	Shares	Sole	2021-02-12
2020-09-30	$1,273,475	45,384	+297.3%	Shares	Sole	2020-10-30
2020-06-30	$337,862	11,422	-55.4%	Shares	Sole	2020-08-05
2020-03-31	$507,350	25,585	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.